Sinew Pharma Inc. (TPEX: 6634)
Health Care · Pharmaceuticals · TW
NT$66.20
+10.33% today · +43.1% 1Y
Sinew Pharma Inc. (TPEX: 6634) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $148.15M and employs 57 people.
Over the last twelve months the share price has gained 43.1%, trading between 29.05 and 85.00.
Tweenvest scores Sinew Pharma Inc. across four factors: quality 42/100, value 63/100. Its strongest factor is value.
6634 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $148.15M
- Revenue (TTM)
- $1.48K
- P/E
- —
- EPS
- -1.66
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- NT$85.00
- 52-week low
- NT$29.05
- Avg volume (3M)
- —
- Shares outstanding
- 71.29M
- Employees
- 57
- Next earnings
- —
About Sinew Pharma Inc.
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
- ISIN
- TW0006634009
- Founded
- 2014
- Listed since
- Jun 30, 2017
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BINEX Co., Ltd.KOSDAQ: A053030 | $151.58M | ₩6,410.00 | +5.78% |
| Memphis Pharmaceuticals & Chemical IndustriesCASE: MPCI | $150.58M | EGP346.51 | -8.81% |
| Quality Chemical Industries LimitedUGSE: QCIL | $149.03M | USh161.88 | +0.55% |
| TTK Healthcare LimitedBSE: 507747 | $148.87M | Rs1,014.35 | -1.60% |
| Panion & Bf Biotech Inc.TWSE: 1760 | $146.96M | NT$54.60 | +1.68% |
| Alexandria Co. For Pharmaceuticals & Chemical IndustriesCASE: AXPH | $143.94M | EGP1,507.07 | -9.02% |
| SunWay Biotech Co., LTD.TPEX: 1271 | $143.91M | NT$59.70 | +2.23% |
| Yungjin Pharm. Co., Ltd.KOSE: A003520 | $141.64M | ₩1,043.00 | +2.05% |
Figures last refreshed Oct 4, 2026.